Brief: Atara Biotherapeutics Announces 1-For-25 Reverse Stock Split
Atara Biotherapeutics Inc ATRA.O :
* ATARA BIOTHERAPEUTICS ANNOUNCES 1-FOR-25 REVERSE STOCK
SPLIT
Source text for Eikon: ID:nBw4Vglpga
Further company coverage: ATRA.O
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing